Product information

Current status:

Cancelled (Unreturned Annual)

Current status date:

2018-04-05

Original market date: ^{See footnote 1}

Product name:

PENTA-TEMAZEPAM CAPSULES

DIN:

02239072 Electronic product monograph is not available

Company:

PENTAPHARM LTD.
3 Glendinning Ave.
Toronto
Ontario
Canada M1W 3E2

Class:

Human

Dosage form(s):

Capsule

Route(s) of administration:

Oral

Number of active ingredient(s):

1

Schedule(s):

Targeted (CDSA IV)

American Hospital Formulary Service (AHFS): ^{See footnote 3}

28:24.08 

Anatomical Therapeutic Chemical (ATC): ^{See footnote 4}

N05CD07 TEMAZEPAM

Active ingredient group (AIG) number:^{See footnote5}

0114415001